5As Team obesity intervention in primary care: development and evaluation of shared decision-making weight management tools

A M Osunlana, J Asselin, R Anderson, A A Ogunleye, A Cave, A M Sharma, D L Campbell-Scherer, A M Osunlana, J Asselin, R Anderson, A A Ogunleye, A Cave, A M Sharma, D L Campbell-Scherer

Abstract

Despite several clinical practice guidelines, there remains a considerable gap in prevention and management of obesity in primary care. To address the need for changing provider behaviour, a randomized controlled trial with convergent mixed method evaluation, the 5As Team (5AsT) study, was conducted. As part of the 5AsT intervention, the 5AsT tool kit was developed. This paper describes the development process and evaluation of these tools. Tools were co-developed by the multidisciplinary research team and the 5AsT, which included registered nurses/nurse practitioners (n = 15), mental health workers (n = 7) and registered dieticians (n = 7), who were previously randomized to the 5AsT intervention group at a primary care network in Edmonton, Alberta, Canada. The 5AsT tool development occurred through a practice/implementation-oriented, need-based, iterative process during learning collaborative sessions of the 5AsT intervention. Feedback during tool development was received through field notes and final provider evaluation was carried out through anonymous questionnaires. Twelve tools were co-developed with 5AsT. All tools were evaluated as either 'most useful' or 'moderately useful' in primary care practice by the 5AsT. Four key findings during 5AsT tool development were the need for: tools that were adaptive, tools to facilitate interdisciplinary practice, tools to help patients understand realistic expectations for weight loss and shared decision-making tools for goal setting and relapse prevention. The 5AsT tools are primary care tools which extend the utility of the 5As of obesity management framework in clinical practice.

Keywords: Obesity; overweight; primary care; weight management implementation tools.

© 2015 The Authors. Clinical Obesity published by John Wiley & Sons Ltd on behalf of World Obesity.

Figures

Figure 1
Figure 1
Usefulness of 5As Team (5AsT) tool kit as graded by 5AsT providers: provider tools.
Figure 2
Figure 2
Usefulness of 5As Team (5AsT) tool kit as graded by 5AsT providers: patient tools.
Figure 3
Figure 3
Usefulness of 5As Team (5AsT) tool kit as graded by 5AsT providers: patient–provider communication tools.

References

    1. Lau DC, Douketis JD, Morrison KM et al 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ 2007; 176: S1–S13.
    1. Rueda‐Clausen C, Benterud E, Bond T et al Effect of implementing the 5As of Obesity Management framework on provider–patient interactions in primary care. Clin Obes 2014; 4: 39–44.
    1. Abid A, Galuska D, Khan LK et al Are healthcare professionals advising obese patients to lose weight? A trend analysis. MedGenMed 2005; 7: 10.
    1. Laws R, Counterweight Project Team . A new evidence‐based model for weight management in primary care: the Counterweight Programme. J Hum Nutr Diet 2004; 17: 191–208.
    1. Beran MS, Fowles JB, Kind EA, Craft CE. State of the Art reviews: patient and physician communication about weight management: can we close the gap? Am J Lifestyle Med 2008; 2: 75–83.
    1. CON Primary Care Working Group, 5As for adults . URL (accessed April 2015)
    1. Campbell‐Scherer DL, Asselin J, Osunlana AM et al Implementation and evaluation of the 5As framework of obesity management in primary care: design of the 5As Team (5AsT) randomized control trial. Implement Sci 2014; 9: 78.
    1. Sharma AM. M, M, M & M: a mnemonic for assessing obesity. Obes Rev 2010; 11: 808–809.
    1. American College of Sports Medicine . ACSM's Guidelines for Exercise Testing and Prescription, 9th edn Lippincott Williams & Wilkins: Philadelphia, 2013.
    1. Gallo MF, Lopez LM, Grimes DA et al Combination contraceptives: effects on weight. Cochrane Database Syst Rev 2014; (1): .
    1. Leucht S, Cipriani A, Spineli L et al Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple‐treatments meta‐analysis. Lancet 2013; 382: 951–962.
    1. Lopez LM, Edelman A, Chen M et al Progestin‐only contraceptives: effects on weight. Cochrane Database Syst Rev 2013; (7): .
    1. Malone M. Medications associated with weight gain. Ann Pharmacother 2005; 39: 2046–2055.
    1. Ness‐Abramof R, Apovian CM. Drug‐induced weight gain. Drugs Today (Barc) 2005; 41: 547–555.
    1. Wadden TA, Foster GD. Behavioral treatment of obesity. Med Clin North Am 2000; 84: 441–461, vii.
    1. Kramer FM, Jeffery RW, Forster JL, Snell MK. Long‐term follow‐up of behavioral treatment for obesity: patterns of weight regain among men and women. Int J Obes 1989; 13: 123–136.
    1. Stiff L, Vogel L, Remington PL. Evaluating the implementation of a primary care weight management toolkit. WMJ 2014; 113: 28–31.
    1. Latham GP, Locke EA. Enhancing the benefits and overcoming the pitfalls of goal setting. Organ Dyn 2006; 35: 332–340.
    1. Knowler WC, Barrett‐Connor E, Fowler SE et al Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403.
    1. Hoffmann TC, Montori VM, Del Mar C. The connection between evidence‐based medicine and shared decision making. JAMA 2014; 312: 1295–1296.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera